An Impact of Allogenetic Blood Transfusion on the Serum Level of Vascular Endothelial Growth Factor

doi:10.3969/j.issn.1671-2587.2017.05.003

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2017, Vol. 19 ›› Issue (5): 424-426.DOI: 10.3969/j.issn.1671-2587.2017.05.003

• Original Articles • Previous Articles Next Articles

An Impact of Allogenetic Blood Transfusion on the Serum Level of Vascular Endothelial Growth Factor

ZHU Xiang, HAN Ling-Fei, LIU Wei-Hong, et al

Maanshan Clinical Laboratory Center,Maanshan 243000

Received:2017-04-25 Online:2017-10-20 Published:2017-10-26

Abstract

Abstract: Objective To investigate the influence of blood transfusion on serum levels of vascular endothelial growth factor （VEGF）. Methods One hundred and twenty patientswere detected and analyzed for VEGF levels with SPSS17.0 softwarebefore or after transfusion. Results The VEGF level of females was found to be significantly higher than that of males following blood transfusion（P<0.05）. No difference was noted in age and blood group. It was fund that the VEGF expression of all subjects investigated seems to be decreased after transfusion compared with those before transfusion.（P<0.01）. Conclusion The VEGF level in the sera of patients was reduced after transfusion,suggesting a possible inhibition of VEGF expression following transfused blood products.

Key words: Blood transfusion, Vascular endothelial growth factor, Blood group

CLC Number:

R457.1

ZHU Xiang, HAN Ling-Fei, LIU Wei-Hong, et al. An Impact of Allogenetic Blood Transfusion on the Serum Level of Vascular Endothelial Growth Factor[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(5): 424-426.

References

1 Tsuchiya K,Asahina Y,Matsuda S,et al.Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma[J]. Cancer,2014,120（2）：229-237.
2 Sullivan LA,Brekken RA. The VEGF family in cancer and antibody-based strategies for their inhibition [J]. MAbs,2010,2（2）：165-175.
3 Lee D,Chung YH,Kim JA,et al.Vascular endothelial growth factor may be a useful predictor of response to combined therapy with sorafenib and transarterial chemoembolization in patients with hepatocellular carcinoma[J]. Hepatology International,2014,8（5）：S276-S277.
4 朱芳,李振宇,任精华,等. VEGF与肿瘤血管生成拟态的研究[J]. 临床肿瘤学杂志,2009,14（1）：20-24.
5 Cao GC,Li XY,Qin C,et al. Prognostic value of VEGF in hepatocellular carcinoma patients treated with sorafenib：A meta-analysis[J]. Med Sci Monit,2015,21：3144-3151.
6 Giaccia A,Siim BG,Johnson RS. HIF-1 as a target for drugdevelopment[J]. Nat Rev Drug Discov,2003,2（10）：803-811.
7 Ferrara N. VEGF and quest for tumor angiogenesis factors[J]. Nat Rev Cancer,2002,2（10）：795-803.
8 Amano H,Kato S,Ito Y,et al.The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia[J].PLoS One,2015,10（7）：1-18.
9 Legros L,Guilhot J,Huault S,et al. Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib[J]. Leuk Res,2014,38（6）：662-665.
10 Chen H,Shen YF,Gong F,et al.Expression of VEGF and its effect on cell proliferation in patients with chronic myeloid leukemia[J].European Review for Medical and Pharmacological Sciences,2015,19（19）：3569-3573.
11 张广宇,赵敏,徐明堂,等.血管内皮生长因子及其受体与肺癌血管新生的研究[J].中华结核和呼吸杂志,2002,25（2）：89-93.
12 陈公琰,洪璇.血管内皮生长因子与肺癌的关系[J].中华肿瘤杂志,2005,27（8）：449-451.
13 Andrew P,Levy NS,Loscalzo J,et al. Regulation of VEGF incardiac myocytes[J]. Circulation,1995,76（5）：758-766

[1]	WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185.
[2]	YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196.
[3]	WANG Wen-ting, DANG Pan-yu, ZHANG Bao-ping, et al. Transfusion Strategy and Prognosis of Hemolytic Disease of the Fetus and Newborn Caused by Anti-D Antibody [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 38-40.
[4]	ZENG Yi-mei, LEI Hang, WANG Yu-qin, et al. ABx Subtype Formation by 1,3-D-Galactosyltransferase p.Arg187Cys Mutation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 41-45.
[5]	LI Li-wei, ZHONG Ning, LI Xing-long, et al. Research on Establishment and Application of Blood Transfusion Sample Distribution Management Model Based on Information System [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 79-82.
[6]	ZHU Lin-lin, ZHAO Qing-wei, ZHANG Chen-guang. Practice of CBL Based on Research Study in The Teaching of Clinical Blood Transfusion Laboratory Medicine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 104-106.
[7]	HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612.
[8]	ZHOU Yao, LUO Hai-yan, SONG Hui-min, et al. Effect of Perioperative Blood Protection Measures on Rapid Rehabilitation of Elderly Patients with Total Hip Arthroplasty [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 617-620.
[9]	WANG Li, LIU Ying, LI Wen-juan, et al. Screening Results and Risk Factors Analysis of Irregular Antibodies in 8 775 Patients Receiving Blood Transfusions [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 480-483.
[10]	CAI Juan, SUN Hong. Analysis of Weak Positive Results of Irregular Antibody Screening [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 484-486.
[11]	WANG Rui-han, FAN Jin-bo, ZHOU Guo-jun, et al. Effect of Intraoperative Cell Salvage on Allogeneic Blood Transfusion and Economic Benefits of Cesarean Women [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 487-492.
[12]	CHEN Bo, CAI Hao-qi, GU Ping, et al. Clinical Analysis of Blood Transfusion in Perioperative Pediatric Orthopaedics [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 497-501.
[13]	LUO Sui-li, YANG Xiao-yong, ZHOU Jun, et al. Identification and Pedigree Analysis of A Case of cisAB Blood Group [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 545-548.
[14]	Chinese Society of Blood Transfusion Clinical Transfusion Management Committee. Investigation and Analysis of Biosafety Protection of Blood Transfusion Departments (Blood Banks) in 2 309 Hospitals during the Epidemic Situation of Novel Coronavirus Pneumonia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 249-252.
[15]	LI Hong-yang, YANG Ji-jun, CHENG Peng, et al. Application of Precise Blood Transfusion Specimen Positioning Information System [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 282-284.

An Impact of Allogenetic Blood Transfusion on the Serum Level of Vascular Endothelial Growth Factor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact